Cullen/Frost Bankers, Inc. Bio Rad Laboratories, Inc. Transaction History

Cullen/Frost Bankers, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$268.26 - $339.48 $1,341 - $1,697	-5 Reduced 55.56%	4 $1,000
Q2 2023 Aug 04, 2023	BUY	$359.49 - $486.4 $3,235 - $4,377	9 New	9 $3,000
Q3 2022 Nov 07, 2022	BUY	$412.59 - $563.26 $825 - $1,126	2 New	2 $1,000
Q2 2022 Aug 05, 2022	SELL	$463.67 - $597.16 $927 - $1,194	-2 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$708.84 - $794.68 $1,417 - $1,589	2 New	2 $2,000
Q1 2020 May 01, 2020	SELL	$320.01 - $409.07 $43,521 - $55,633	-136 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$319.73 - $374.2 $23,340 - $27,316	73 Added 115.87%	136 $50,000
Q3 2019 Nov 01, 2019	BUY	$304.55 - $345.24 $7,309 - $8,285	24 Added 61.54%	63 $21,000
Q2 2019 Aug 01, 2019	BUY	$286.93 - $312.59 $11,190 - $12,191	39 New	39 $12,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.